By ZetaKap : Interested in gaining exposure to biotechnology companies? Do you prefer stocks that are projected to grow over the long term? Do you prefer investing in stocks that analysts have weighed in on? If so, here's a list you might be interested in. EPS growth (earnings per share growth) ...
… would like to welcome everyone to the Athersys First Quarter 2012 Financial Results ..... Communications, Investor Relations for Athersys . Thank you for joining today's call ..... it, the release is available on the Athersys website at athersys .com or you may …
Premarket gainers: ARNA +93% . GV +45.5% . ATHX +15% . AVG +12% . ZOOM +9% . MDR +9% . SOL +8% . NVDA +8% . Losers: RNDY -11% . PBTH -11% . DAR -9% . JPM -8.5% . SNE -8% . Post your comment!
… headquartered in Houston, Texas, announcing that it had raised $20 million in a Series B financing. Then the news from Athersys ( ATHX ) announced a PIPE financing of $9 million presumed to be largely dedicated to its current pipeline of Phase I and …
Athersys ( ATHX ) +8.9% premarket after announcing its met with the FDA to discuss results of its recent clinical trial involving the administration …
… would like to welcome everyone to the Athersys Fourth Quarter 2011 Financial Results ..... Communications, Investor Relations for Athersys . Thank you for joining today s call ..... it, the release is available on the Athersys website at athersys .com or you may …
Shares of Athersys ( ATHX +3.2% ) bounce higher after the firm presents positive data on its MultiStem heart stroke treatment. The firm believes the stroke market represents a commercial opportunity of more than $15B annually. Post your comment!
Microcap biotech research firm Athersys ( ATHX +8% ) jumps after disclosing $3.6M in grant funding to further advance its MultiStem product research and development programs and other cell therapy platforms. Post your comment!
We are no longer providing equity research on Athersys ATHX . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.
… went unnoticed by investors, Athersys , Inc. ( ATHX ), a clinical stage biopharmaceutical ..... promising program. I first discussed Athersys in depth in a Seeking Alpha article ..... favor in the ensuing months, Athersys hasn’t been an exception and …